microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass

Background The systemic inflammation that occurs after exposure to cardiopulmonary bypass (CPB), which is especially severe in neonatal patients, is associated with poorer outcomes and is not well understood. In order to gain deeper insight into how exposure to bypass activates inflammatory response...

Full description

Bibliographic Details
Main Authors: Lance Hsieh, Lan N. Tu, Alison Paquette, Quanhu Sheng, Shilin Zhao, Douglas Bittel, James O’Brien, Kasey Vickers, Peter Pastuszko, Vishal Nigam
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.025864
_version_ 1828379172996644864
author Lance Hsieh
Lan N. Tu
Alison Paquette
Quanhu Sheng
Shilin Zhao
Douglas Bittel
James O’Brien
Kasey Vickers
Peter Pastuszko
Vishal Nigam
author_facet Lance Hsieh
Lan N. Tu
Alison Paquette
Quanhu Sheng
Shilin Zhao
Douglas Bittel
James O’Brien
Kasey Vickers
Peter Pastuszko
Vishal Nigam
author_sort Lance Hsieh
collection DOAJ
description Background The systemic inflammation that occurs after exposure to cardiopulmonary bypass (CPB), which is especially severe in neonatal patients, is associated with poorer outcomes and is not well understood. In order to gain deeper insight into how exposure to bypass activates inflammatory responses in circulating leukocytes, we studied changes in microRNA (miRNA) expression during and after exposure to bypass. miRNAs are small noncoding RNAs that have important roles in modulating protein levels and function of cells. Methods and Results We performed miRNA‐sequencing on leukocytes isolated from neonatal patients with CPB (n=5) at 7 time points during the process of CPB, including before the initiation of bypass, during bypass, and at 3 time points during the first 24 hours after weaning from bypass. We identified significant differentially expressed miRNAs using generalized linear regression models, and miRNAs were defined as statistically significant using a false discovery rate–adjusted P<0.05. We identified gene targets of these miRNAs using the TargetScan database and identified significantly enriched biological pathways for these gene targets. We identified 54 miRNAs with differential expression during and after CPB. These miRNAs clustered into 3 groups, including miRNAs that were increased during and after CPB (3 miRNAs), miRNAs that decreased during and after CPB (10 miRNAs), and miRNAs that decreased during CPB but then increased 8 to 24 hours after CPB. A total of 38.9% of the target genes of these miRNAs were significantly differentially expressed in our previous study. miRNAs with altered expression levels are predicted to significantly modulate pathways related to inflammation and signal transduction. Conclusions The unbiased profiling of the miRNA changes that occur in the circulating leukocytes of patients with bypass provides deeper insight into the mechanisms that underpin the systemic inflammatory response that occurs in patients after exposure to CPB. These data will help the development of novel treatments and biomarkers for bypass‐associated inflammation.
first_indexed 2024-12-10T03:35:55Z
format Article
id doaj.art-3cec4c77430c4f409061127ace36ec7c
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-10T03:35:55Z
publishDate 2022-09-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-3cec4c77430c4f409061127ace36ec7c2022-12-22T02:03:42ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-09-01111710.1161/JAHA.122.025864microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary BypassLance Hsieh0Lan N. Tu1Alison Paquette2Quanhu Sheng3Shilin Zhao4Douglas Bittel5James O’Brien6Kasey Vickers7Peter Pastuszko8Vishal Nigam9Department of Pediatrics (Cardiology) University of Washington Seattle WADepartment of Pediatrics (Cardiology) University of Washington Seattle WACenter for Developmental Biology and Regenerative Medicine Seattle Children’s Research Institute Seattle WADepartment of Biostatistics Vanderbilt University Medical Center Nashville TNDepartment of Biostatistics Vanderbilt University Medical Center Nashville TNWard Family Heart Center Children’s Mercy Hospital Kansas City MOWard Family Heart Center Children’s Mercy Hospital Kansas City MODepartment of Medicine Vanderbilt University Medical Center Nashville TNDepartment of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai New York NYDepartment of Pediatrics (Cardiology) University of Washington Seattle WABackground The systemic inflammation that occurs after exposure to cardiopulmonary bypass (CPB), which is especially severe in neonatal patients, is associated with poorer outcomes and is not well understood. In order to gain deeper insight into how exposure to bypass activates inflammatory responses in circulating leukocytes, we studied changes in microRNA (miRNA) expression during and after exposure to bypass. miRNAs are small noncoding RNAs that have important roles in modulating protein levels and function of cells. Methods and Results We performed miRNA‐sequencing on leukocytes isolated from neonatal patients with CPB (n=5) at 7 time points during the process of CPB, including before the initiation of bypass, during bypass, and at 3 time points during the first 24 hours after weaning from bypass. We identified significant differentially expressed miRNAs using generalized linear regression models, and miRNAs were defined as statistically significant using a false discovery rate–adjusted P<0.05. We identified gene targets of these miRNAs using the TargetScan database and identified significantly enriched biological pathways for these gene targets. We identified 54 miRNAs with differential expression during and after CPB. These miRNAs clustered into 3 groups, including miRNAs that were increased during and after CPB (3 miRNAs), miRNAs that decreased during and after CPB (10 miRNAs), and miRNAs that decreased during CPB but then increased 8 to 24 hours after CPB. A total of 38.9% of the target genes of these miRNAs were significantly differentially expressed in our previous study. miRNAs with altered expression levels are predicted to significantly modulate pathways related to inflammation and signal transduction. Conclusions The unbiased profiling of the miRNA changes that occur in the circulating leukocytes of patients with bypass provides deeper insight into the mechanisms that underpin the systemic inflammatory response that occurs in patients after exposure to CPB. These data will help the development of novel treatments and biomarkers for bypass‐associated inflammation.https://www.ahajournals.org/doi/10.1161/JAHA.122.025864cardiopulmonary bypassinflammationmicroRNAneonate
spellingShingle Lance Hsieh
Lan N. Tu
Alison Paquette
Quanhu Sheng
Shilin Zhao
Douglas Bittel
James O’Brien
Kasey Vickers
Peter Pastuszko
Vishal Nigam
microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiopulmonary bypass
inflammation
microRNA
neonate
title microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass
title_full microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass
title_fullStr microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass
title_full_unstemmed microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass
title_short microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass
title_sort microrna expression levels change in neonatal patients during and after exposure to cardiopulmonary bypass
topic cardiopulmonary bypass
inflammation
microRNA
neonate
url https://www.ahajournals.org/doi/10.1161/JAHA.122.025864
work_keys_str_mv AT lancehsieh micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT lanntu micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT alisonpaquette micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT quanhusheng micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT shilinzhao micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT douglasbittel micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT jamesobrien micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT kaseyvickers micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT peterpastuszko micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass
AT vishalnigam micrornaexpressionlevelschangeinneonatalpatientsduringandafterexposuretocardiopulmonarybypass